Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study by Dreyling, Martin, Prof Dr, Jurczak, Wojciech, MD, Jerkeman, Mats, MD, Silva, Rodrigo Santucci, MD, Rusconi, Chiara, MD, Trneny, Marek, Prof, Offner, Fritz, MD, Caballero, Dolores, MD, Joao, Cristina, Prof, Witzens-Harig, Mathias, Prof, Hess, Georg, MD, Bence-Bruckler, Isabelle, MD, Cho, Seok-Goo, Prof, Bothos, John, PhD, Goldberg, Jenna D, MD, Enny, Christopher, BS, Traina, Shana, PhD, Balasubramanian, Sriram, PhD, Bandyopadhyay, Nibedita, PhD, Sun, Steven, PhD, Vermeulen, Jessica, MD, Rizo, Aleksandra, MD, Rule, Simon, Prof

Get full text